Skip to main content

Table 2 Frequency distribution of NAT2 genotypes in prostate cancer patients and controls.

From: Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population

Patients

NAT2 genotype

P – value

Unadjusted OR (95% CI)

Adjusted OR

 

Slow – acetylators

Rapid-acetylators

   

Controls (n = 140)

62 (44.29%)

78 (55.71%)

 

1.0 (Reference)

1.0

Prostate cancer (n = 130)

46 (35.38%)

84 (64.62%)

0.136

1.452 (0.54–1.87)

1.348 (0.39–2.28)

  1. Adjusted OR = Age adjusted odds ratio.